Literature DB >> 30715396

Cardiac Disease After Breast Cancer Treatment: Make Sure to Check Our Blind Spot!

Daniel J Lenihan1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30715396      PMCID： PMC6695301          DOI： 10.1093/jnci/djy219

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort.

Authors:  Anthony A Bavry; Yan Gong; Eileen M Handberg; Rhonda M Cooper-DeHoff; Carl J Pepine
Journal:  Am J Med       Date:  2014-10-15       Impact factor: 4.965

2.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

3.  Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.

Authors:  Jersey Chen; Jessica B Long; Arti Hurria; Cynthia Owusu; Richard M Steingart; Cary P Gross
Journal:  J Am Coll Cardiol       Date:  2012-11-14       Impact factor: 24.094

Review 4.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

5.  An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk.

Authors:  Lynsey Rice; Christy Goldsmith; Melanie Ml Green; Susan Cleator; Patricia M Price
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-06-14

6.  The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.

Authors:  Husam Abdel-Qadir; Paaladinesh Thavendiranathan; Peter C Austin; Douglas S Lee; Eitan Amir; Jack V Tu; Kinwah Fung; Geoffrey M Anderson
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

7.  Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.

Authors:  Erin J Aiello Bowles; Robert Wellman; Heather Spencer Feigelson; Adedayo A Onitilo; Andrew N Freedman; Thomas Delate; Larry A Allen; Larissa Nekhlyudov; Katrina A B Goddard; Robert L Davis; Laurel A Habel; Marianne Ulcickas Yood; Catherine McCarty; David J Magid; Edward H Wagner
Journal:  J Natl Cancer Inst       Date:  2012-09-05       Impact factor: 13.506
  7 in total
  1 in total

1.  Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin.

Authors:  Sebastian Szmit; Aleksandra Grela-Wojewoda; Małgorzata Talerczyk; Joanna Kufel-Grabowska; Joanna Streb; Jolanta Smok-Kalwat; Dariusz Iżycki; Ewa Chmielowska; Michał Wilk; Barbara Sosnowska-Pasiarska
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.